Case study: persistent keratitis OS presents in 68-year-old woman

Publication
Article
Optometry Times JournalDigital edition: January 2022
Volume 14
Issue 01

A 68-year-old White woman was referred for persistent keratitis OS and failure on multiple medications. Find out her official diagnosis and treatment plan.

Figure 1. Infectious keratitis before application of Prokera Slim.

Figure 1. Infectious keratitis before application of Prokera Slim.



Presentation

A 68-year-old White woman was referred for persistent keratitis OS and failure on multiple medications: Restasis, Xiidra, prednisolone 1%, Lotemax 0.5%, and Cequa. She was using Systane preservative-free drops, 4 to 6 times daily. Sodium fluorescein staining revealed marked keratitis OS (Figure 1).

Greg Caldwell

Caldwell

Treatment

I educated the patient about her condition, and after lengthy discussion it was decided that a Prokera Slim amniotic membrane would be used to treat the OS.

Follow-up

I instructed my patient to make an appointment to have the Prokera ring removed when her vision cleared (due to membrane dissolving). Her vision cleared 6 days after Prokera Slim insertion. At this point, she was only using Systane preservative-free artificial tears. The ring was removed, and the patient was placed on autologous serum eye drops 20%, 1 drop 6 times per day.

Figure 2. The eye 6 days after application of Prokera Slim. (All figures courtesy of Greg Caldwell, OD, FAAO)

Figure 2. The eye 6 days after application of Prokera Slim. (All figures courtesy of Greg Caldwell, OD, FAAO)


Outcome and observations

The patient presented with a chronic and persistent keratitis OS. The cause was multifactorial with 1 component being toxic keratitis from the various pharmaceuticals used. This patient needed a therapy that supported wound healing and not wound covering. A Prokera Slim was used to provide wound healing. The patient reported no problems or discomfort with Prokera Slim during the 6-day treatment (Figure 2).

The patient responded wonderfully to the therapy and reported increased comfort and improved vision.

READ Dr.Caldwell's full article: Cryopreserved amniotic membrane excels at healing ocular surface wounds

Recent Videos
Abby Gillogly Harsch, OD, FAAO, FSLS, shares a specific complex case of scleral lens fitting that she presented on at this year's GSLS.
Katie Rachon, OD, FAAO, Dipl ABO, shares her excitement for the upcoming conference and what it means for an optometrist's toolbox.
From contact lens dropout to addressing diabetic retinopathy in rural communities, optometrists choose an area of eye care research that they would expand, given the appropriate resources.
From new treatments on the horizon for macular degeneration to strengthening comanagement ties, optometrists cite a lot to be excited about in the coming year.
Practice owners testify to the importance of trying new things, not being afraid to fail, and utilizing community as a resource when starting up a new practice.
Optometrists reflect on their residency experiences and provide advice to current residents.
In 2 weeks, the study participant's dry eye symptoms improved from 76 to 43 on a 0-100 rating scale, according to Marc-Matthias Schulze, PhD, Dipl Ing.
Eye care practitioners reported moderate to high satisfaction with lifitegrast's ability to improve signs of dry eye, according to Melissa Barnett, OD, FAAO, FSLS.
Neda Gioia, OD, CNS, FOWNS, details the positive feedback gained so far from other optometrists that have been prescribing the NutriTears supplement to their dry eye patients.
Damaris Raymondi, OD, FAAO, highlighted the importance of building patient-doctor trust to learn about these practices, which can include non-traditional treatments like chamomile or manuka honey eye drops.
© 2025 MJH Life Sciences

All rights reserved.